Влияние недавних изменений в GVP ЕАЭС
January 21, 2025
Inpharmatis appoints new RA Director in Russia & CIS
Inpharmatis officially announces the appointment of Olga Zvonareva to the position of Regional Regulatory Affairs Director in Russia and the CIS countries.
As part of the international Inpharmatis team, Olga Zvonareva is to strengthen the company's position in the market of Russia and the CIS countries in the field of providing a full range of services for the registration of medicines and medical devices. Olga Zvonareva will work in the Moscow office of Inpharmatis.
Prior to joining Inpharmatis, Olga Zvonareva held the position of Director for Regulatory Affairs, Pharmacovigilance and Quality Management at the European pharmaceutical company Fresenius Kabi for over 15 years.
Inpharmatis is an international consulting group of companies headquartered in Riga, Latvia. Inpharmatis provides a full range of services for Regulatory Affairs, pharmacovigilance (PV), GMP and GDP audits, PIL Readability User Testing, as well as electronic solutions for the pharmaceutical companies and regulatory authorities in the European Union, EAEU, CIS.


Impact of Recent Changes in EAEU GVP
January 21, 2025
Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024